Purdue Probed Over Opioid Relief Claim
- Company executives had pleaded guilty to misbranding in 2007
- States, cities and counties suing over opioid epidemic in U.S.
How America's Opioid Crisis Spiraled Out of Control
This article is for subscribers only.
Federal prosecutors in Connecticut began a criminal investigation into Purdue Pharma Inc.’s marketing of the controversial opioid painkiller OxyContin.
U.S. Attorney Deirdre Daly is gathering documents about Purdue’s claim that OxyContin provides 12 hours of pain relief. A Los Angeles Times investigation, published last year, found that Purdue ignored evidence showing the drug’s effects failed to last that long in some patients, increasing the risk of withdrawal, abuse and addiction.